Universe Change In Cash vs Net Borrowings Analysis

UPC Stock  USD 0.64  0.01  1.46%   
Universe Pharmaceuticals financial indicator trend analysis is much more than just breaking down Universe Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Universe Pharmaceuticals is a good investment. Please check the relationship between Universe Pharmaceuticals Change In Cash and its Net Borrowings accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.

Change In Cash vs Net Borrowings

JavaScript chart by amCharts 3.21.15201420162018202020222024-3M-2M-1M01M2M3M4M5M6M -1.5M-1M-500K0500K1M1.5M2M2.5M3M3.5M4M
JavaScript chart by amCharts 3.21.15Change In Cashtotal: -5.7MNet Borrowingstotal: 6.7M

Change In Cash vs Net Borrowings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Universe Pharmaceuticals Change In Cash account and Net Borrowings. At this time, the significance of the direction appears to have no relationship.
Change In CashNet BorrowingsDiversified AwayChange In CashNet BorrowingsDiversified Away100%
The correlation between Universe Pharmaceuticals' Change In Cash and Net Borrowings is 0.07. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Net Borrowings in the same time period over historical financial statements of Universe Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Universe Pharmaceuticals' Change In Cash and Net Borrowings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of Universe Pharmaceuticals are associated (or correlated) with its Net Borrowings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Borrowings has no effect on the direction of Change In Cash i.e., Universe Pharmaceuticals' Change In Cash and Net Borrowings go up and down completely randomly.

Correlation Coefficient

0.07
Relationship DirectionPositive 
Relationship StrengthInsignificant

Change In Cash

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.
Most indicators from Universe Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Universe Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.As of December 26, 2024, Tax Provision is expected to decline to about 1.6 M. In addition to that, Selling General Administrative is expected to decline to about 1.8 M
 2021 2022 2023 2024 (projected)
Interest Expense162.4K156.8K180.3K153.8K
Depreciation And Amortization533.9K508.8K457.9K413.1K

Universe Pharmaceuticals fundamental ratios Correlations

0.85-0.57-0.20.970.970.96-0.340.420.830.880.210.980.930.980.93-0.34-0.65-0.620.950.96-0.20.97-0.40.910.85
0.85-0.58-0.180.830.890.95-0.440.650.590.88-0.020.90.880.90.68-0.44-0.67-0.60.740.93-0.180.85-0.610.961.0
-0.57-0.580.89-0.74-0.73-0.610.34-0.33-0.82-0.45-0.16-0.62-0.66-0.65-0.650.340.970.97-0.66-0.630.89-0.740.43-0.57-0.58
-0.2-0.180.89-0.43-0.4-0.240.12-0.12-0.62-0.01-0.07-0.27-0.31-0.29-0.390.120.840.86-0.36-0.281.0-0.420.19-0.21-0.18
0.970.83-0.74-0.430.990.95-0.340.420.920.810.210.970.940.980.95-0.34-0.81-0.780.970.96-0.431.0-0.420.890.83
0.970.89-0.73-0.40.990.97-0.330.460.880.850.170.980.940.990.92-0.33-0.8-0.770.940.98-0.41.0-0.430.930.89
0.960.95-0.61-0.240.950.97-0.380.60.750.890.030.990.950.970.84-0.38-0.71-0.650.891.0-0.240.96-0.510.980.95
-0.34-0.440.340.12-0.34-0.33-0.38-0.55-0.28-0.37-0.11-0.36-0.59-0.36-0.331.00.360.36-0.27-0.360.12-0.350.94-0.38-0.44
0.420.65-0.33-0.120.420.460.6-0.550.140.4-0.650.550.640.420.22-0.55-0.42-0.350.350.59-0.120.44-0.760.650.65
0.830.59-0.82-0.620.920.880.75-0.280.140.640.420.810.790.850.94-0.28-0.83-0.840.910.77-0.620.91-0.260.650.59
0.880.88-0.45-0.010.810.850.89-0.370.40.640.230.850.810.870.7-0.37-0.47-0.410.830.84-0.010.83-0.40.810.88
0.21-0.02-0.16-0.070.210.170.03-0.11-0.650.420.230.060.080.250.4-0.11-0.1-0.170.220.02-0.070.20.12-0.05-0.02
0.980.9-0.62-0.270.970.980.99-0.360.550.810.850.060.960.980.89-0.36-0.72-0.670.930.99-0.270.98-0.470.950.9
0.930.88-0.66-0.310.940.940.95-0.590.640.790.810.080.960.940.87-0.59-0.75-0.710.880.95-0.310.94-0.670.920.88
0.980.9-0.65-0.290.980.990.97-0.360.420.850.870.250.980.940.93-0.36-0.74-0.710.920.97-0.290.98-0.450.940.9
0.930.68-0.65-0.390.950.920.84-0.330.220.940.70.40.890.870.93-0.33-0.73-0.750.920.86-0.390.94-0.340.780.68
-0.34-0.440.340.12-0.34-0.33-0.381.0-0.55-0.28-0.37-0.11-0.36-0.59-0.36-0.330.360.36-0.27-0.360.12-0.350.94-0.38-0.44
-0.65-0.670.970.84-0.81-0.8-0.710.36-0.42-0.83-0.47-0.1-0.72-0.75-0.74-0.730.360.99-0.69-0.740.84-0.810.49-0.7-0.67
-0.62-0.60.970.86-0.78-0.77-0.650.36-0.35-0.84-0.41-0.17-0.67-0.71-0.71-0.750.360.99-0.67-0.690.86-0.780.47-0.64-0.6
0.950.74-0.66-0.360.970.940.89-0.270.350.910.830.220.930.880.920.92-0.27-0.69-0.670.89-0.360.96-0.290.790.74
0.960.93-0.63-0.280.960.981.0-0.360.590.770.840.020.990.950.970.86-0.36-0.74-0.690.89-0.280.96-0.50.980.93
-0.2-0.180.891.0-0.43-0.4-0.240.12-0.12-0.62-0.01-0.07-0.27-0.31-0.29-0.390.120.840.86-0.36-0.28-0.420.19-0.21-0.18
0.970.85-0.74-0.421.01.00.96-0.350.440.910.830.20.980.940.980.94-0.35-0.81-0.780.960.96-0.42-0.430.90.85
-0.4-0.610.430.19-0.42-0.43-0.510.94-0.76-0.26-0.40.12-0.47-0.67-0.45-0.340.940.490.47-0.29-0.50.19-0.43-0.57-0.61
0.910.96-0.57-0.210.890.930.98-0.380.650.650.81-0.050.950.920.940.78-0.38-0.7-0.640.790.98-0.210.9-0.570.96
0.851.0-0.58-0.180.830.890.95-0.440.650.590.88-0.020.90.880.90.68-0.44-0.67-0.60.740.93-0.180.85-0.610.96
Click cells to compare fundamentals

Universe Pharmaceuticals Account Relationship Matchups

Universe Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets28.8M70.1M59.5M53.3M61.3M47.2M
Short Long Term Debt Total2.6M4.3M3.9M5.5M6.3M3.9M
Other Current Liab1.3M464.0K5.9M3.3M2.9M3.2M
Total Current Liabilities8.0M11.2M13.1M13.8M15.8M12.8M
Total Stockholder Equity20.8M58.9M46.4M39.5M45.5M34.4M
Net Tangible Assets12.2M20.6M58.8M46.3M53.2M32.4M
Property Plant And Equipment Net4.4M15.4M13.6M15.0M17.2M10.6M
Net Debt(7.4M)(3.7M)(1.8M)197.2K226.8K238.1K
Retained Earnings13.7M25.1M16.3M10.2M11.7M13.6M
Accounts Payable2.7M5.3M3.1M4.6M5.3M3.8M
Cash10.1M8.1M5.7M5.3M6.1M7.1M
Non Current Assets Total5.5M19.7M18.0M16.5M18.9M13.1M
Other Assets168.1K186.5K14.1M12.9M14.9M15.6M
Cash And Short Term Investments10.1M21.8M18.9M18.5M21.3M14.4M
Net Receivables10.9M15.8M15.2M10.7M12.3M12.2M
Liabilities And Stockholders Equity28.8M70.1M59.5M53.3M61.3M47.2M
Inventory1.9M2.5M2.2M3.3M3.0M2.8M
Other Current Assets443.7K10.4M5.3M4.2M4.9M3.7M
Total Liab8.0M11.2M13.1M13.8M15.8M12.8M
Net Invested Capital23.4M63.3M50.4M45.0M51.8M38.4M
Long Term Investments735K744.9K702.9K685.3K616.8K572.9K
Property Plant And Equipment Gross4.4M15.4M19.3M21.0M24.2M12.8M
Short Long Term Debt2.6M4.3M3.9M5.5M6.3M3.9M
Total Current Assets23.3M50.5M41.5M36.8M42.3M34.1M
Accumulated Other Comprehensive Income3.3M4.5M772.8K26.3K23.6K22.5K
Net Working Capital15.3M39.3M28.4M23.1M26.5M21.3M
Short Term Debt2.6M4.3M3.9M5.5M6.3M3.9M
Intangible Assets174.8K178.5K157.5K148.6K133.7K135.3K
Property Plant Equipment4.6M4.4M4.7M4.3M3.8M3.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.82)
Earnings Share
(76.35)
Revenue Per Share
7.351
Quarterly Revenue Growth
(0.30)
Return On Assets
(0.06)
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.